Amphetamine-induced c- fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotype by Uslaner, Jason M. et al.
Amphetamine-induced c-fos mRNA expression in the
caudate-putamen and subthalamic nucleus: interactions between
dose, environment, and neuronal phenotype
Jason M. Uslaner,* Camille S. Norton, Stanley J. Watson, Huda Akil and Terry E. Robinson*
*Biopsychology and Neuroscience Programs, Department of Psychology, Mental Health Research Institute and Department
of Psychiatry, The University of Michigan, Ann Arbor, Michigan, USA
Abstract
When administered in a novel environment relatively low
doses of amphetamine induce c-fos mRNA in the subthalamic
nucleus (STN) and in preproenkephalin mRNA-containing
(ENK+) neurons in the caudate-putamen (CPu). When
administered at home, however, low doses of amphetamine
do not produce these effects. Environmental novelty also
facilitates the behavioral effects of acute and repeated
amphetamine, but this is dose-dependent. The purpose of the
present experiment therefore was to determine if the effect of
context on amphetamine-induced c-fos expression is also
dose-dependent. It was found that: (i) No dose of amphet-
amine tested (1–10 mg/kg) induced c-fos in many ENK+ cells
when given at home. (ii) When given in a novel environment
low to moderate doses of amphetamine (1–5 mg/kg) induced
c-fos in substantial numbers of ENK+ cells, but the highest
dose examined (10 mg/kg) did not. (iii) Environmental novelty
enhanced the ability of low to moderate doses of amphet-
amine to induce c-fos in the STN, but the highest dose of
amphetamine induced robust c-fos mRNA expression in the
STN regardless of context. The results do not support the idea
that engaging ENK+ cells, at least as indicated by c-fos mRNA
expression, is critical to produce robust behavioral sensitiza-
tion, but do suggest a possible role for the STN. Furthermore,
the results highlight the importance of drug–environment
interactions on the neurobiological effects of drugs, and have
implications for thinking about the circuits by which context
modulates the acute and long-lasting consequences of
amphetamine treatment.
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The ability of amphetamine and cocaine to induce the
expression of immediate early genes (IEGs) in the caudate-
putamen (CPu) depends upon the context in which these
drugs are administered (Badiani et al. 1998; Uslaner et al.
2001a; Klebaur et al. 2002). Amphetamine or cocaine given
in the home cage induces IEGs preferentially in striatonigral
neurons that coexpress mRNA for the dopamine D1 receptor,
preprodynorphin, and preprotachykinin (substance P; SP+
cells) (Berretta et al. 1992; Cenci et al. 1992; Berretta et al.
1993; Johansson et al. 1994; Ruskin and Marshall 1994;
Kosofsky et al. 1995; Berke et al. 1998). Under these
conditions, psychostimulants fail to induce IEGs in many
striatopallidal neurons that coexpress mRNA for the dopam-
ine D2 receptor and preproenkephalin (ENK+ cells). How-
ever, when given in a distinct and novel test cage these drugs
induce the IEG c-fos and Fos protein in both SP+ and ENK+
cells (Jaber et al. 1995; Badiani et al. 1999; Uslaner et al.
2001b). Furthermore, when given in a novel test cage, these
drugs induce much more robust c-fos expression in the
subthalamic nucleus (STN) (Ostrander et al. 2000; Uslaner
et al. 2001b), a structure that receives input from ENK+ cells
via the so-called ‘indirect pathway’ (Albin et al. 1989).
In addition to modulating psychostimulant-induced c-fos
expression in the CPu and STN, environmental novelty also
modulates the acute psychomotor activating effects of amphet-
amine, as well as its ability to produce a form of drug-
experience dependent plasticity, behavioral sensitization.
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When given in a novel environment amphetamine produces
more robust psychomotor activation, and more robust
behavioral sensitization than when given in the home cage
(Badiani et al. 1995a; Badiani et al. 1995b; Crombag et al.
1996; Badiani et al. 1997). We hypothesized therefore that
the ability of environmental novelty to recruit ENK+ cells in
the CPu and to engage the STN may be related to the ability
of environmental novelty to enhance amphetamine-induced
psychomotor activation and behavioral sensitization (Badiani
et al. 1999; Uslaner et al. 2001b).
To explore this hypothesis we took advantage of the fact
that the ability of environmental novelty to modulate
amphetamine-induced psychomotor activation and behavi-
oral sensitization is not absolute, but it is dose-dependent. As
the dose of amphetamine is increased, the effect of environ-
mental context is lost, such that relatively high doses
promote robust psychomotor activation and robust behavi-
oral sensitization, whether they are given in a novel
environment or at home (Browman et al. 1998a,b). The
current study was designed therefore to characterize interac-
tions between the effects of dose and environmental context
on amphetamine-evoked c-fos mRNA expression in the STN
and in SP+ and ENK+ cells in the CPu. We hypothesized that
if recruiting the STN or ENK+ cells in the CPu is important
to facilitate acute psychomotor activation and/or behavioral
sensitization, as dose is increased amphetamine should come




Eighty male Sprague–Dawley rats (Harlan, Indianapolis, IN, USA)
weighing 200–250 g were initially housed individually in square
plastic clear cages that had pine shavings on the floor and food and
water freely available. The room was kept at a constant temperature
and humidity and was on a 14 : 10 h light/dark cycle (lights on at
7 : 00 h). The animals were acclimated to the colony room for
7 days prior to any experimental manipulation. All experimental
procedures were approved by the University of Michigan Commit-
tee on the Use and Care of Animals.
Drugs
D-Amphetamine sulfate (1, 5, or 10 mg/mL) was dissolved in 0.9%
saline and administered in a volume of 1 mL/kg via intraperitoneal
(i.p.) injection. All drug weights refer to the weight of the salts.
Testing procedures
Rats were randomly assigned to one of eight groups (n ¼ 10 per
group). Animals in four of the groups (home groups) were
transferred from the main animal colony room to a room where
they were housed in circular orange plastic buckets (25 cm diameter
at base) with ground corncob bedding on the floor. They remained in
these buckets with food and water available ad libitum for the rest of
the experiment. Animals in the other four groups (novel groups)
were left in the clear square cages in the animal colony room. Ten
days later, rats in the home groups were administered saline or 1, 5,
or 10 mg/kg of amphetamine in their home cages. Rats in the four
novel groups were transferred from their cages in the main colony
room to the circular orange buckets (for them a novel environment)
identical to the ones in which the home groups lived, and were
immediately administered saline or 1, 5, or 10 mg/kg of amphet-
amine. We chose this dose range because 1 mg/kg of amphetamine
is just above the threshold dose necessary for inducing robust
behavioral sensitization (Segal 1975), and doses between 7.5 and
10 mg/kg promote robust behavioral sensitization without produ-
cing marked dyskinetic effects (Segal and Mandell 1974; Taylor
et al. 1974; Eichler et al. 1980).
Fifty minutes following treatment, each rat was decapitated. Its
brain was removed, immediately frozen in isopentane () 40 to
) 50C), and then stored in a ) 70C freezer until it was sectioned.
A cryostat was used to cut 10 lm thick coronal sections at the level
of the CPu and the STN (approximately 0.8 and 4 mm posterior to
bregma, respectively). The sections were thaw-mounted on slides
coated with polylysine and stored at ) 70C until processing for
in situ hybridization.
In situ hybridization and quantification of mRNA
All in situ hybridization methods were as described in previous
experiments (Uslaner et al. 2001b) except that the dual in situ
hybridization was performed using [35S]UTP and [35S]CTP-labeled
riboprobes for c-fos mRNA (680-mer; courtesy of Dr T. Curran),
and digoxigenin-UTP-labeled riboprobes complimentary for pre-
protachykinin or preproproenkephalin mRNA (567-mer and 693-
mer, respectively; courtesy of Dr J. Douglass, Amgen, Thousand
Oaks, CA, USA). The single in situ hybridization method was
adapted from that described by Cullinan et al. (1995) and the double
in situ hybridization method from that by Curran and Watson
(1995). Sections containing the STN were processed for single in situ
hybridization using the riboprobe complementary to c-fos. Sections
containing the CPu were processed for dual in situ hybridization
using the riboprobe complimentary to c-fos and preprotachykinin or
preproenkephalin. Single-labeled sections were exposed to X-ray
film (Kodak Biomax, MR) for approximately 3 days. Double-
labeled sections were dipped in Ilford KD-5 emulsion (Polyscienc-
es) and stored at 4C (approximately 7 days). After development
(Kodak D-19), the slides were dehydrated in graded alcohols and
coverslipped with Permount.
Quantification
Single-labeled sections were quantified as described previously
(Badiani et al. 1998). Briefly, brain images were captured with
a Sony CCD camera from the X-ray film, and semiquantitative
analysis was performed on the digitized autoradiograms using
National Institute of Health Image Software. Pixels were counted
when the optical density values were at least 3.5 standard deviations
above background value (background obtained from corpus callo-
sum; macro written by Dr S. Campeau, University of Colorado,
Boulder). Thus, the data are represented as relative integrated
optical density in arbitrary units, which reflects both signal intensity
and the number of pixels above background, divided by total area
(see Badiani et al. 1998; Day et al. 2001). Adjacent sections were
stained with cresyl violet to help with anatomical location.
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Double-labeled tissue from the CPu was quantified using a Leica
microscope (Leitz DMR, Wetzler, Germany) at a total magnification
of 200 ·. Digoxigenin-labeled cells appeared as a purple precipitate
in brightfield conditions and 35S-labeled cells appeared as densely
packed silver grains in darkfield conditions. We analyzed a
500 · 500 lm portion of the dorsomedial and dorsolateral CPu in
each hemisphere. There were no differences in cell counts between
these areas, so they were combined. Figure 1 shows the portion of
the CPu that was analyzed. We examined this portion of the CPu
because in previous studies we found the drug–environment
interaction is greatest in the caudal CPu (Uslaner et al. 2001a).
Controls
In order to ensure that non-specific binding was minimal we
performed control experiments on striatal tissue using sense strands
for c-fos, preprotachykinin, and preproenkephalin mRNA. There
was no binding of the sense probes. Furthermore, we examined
whether the preprotachykinin and preproenkephalin antisense
probes labeled separate cells within the CPu by performing dual
in situ hybridization using [35S]UTP and [35S]CTP labeled
preprotachykinin and digoxigenin-UTP labeled preproenkephalin.
We examined the same region of the CPu as in the rest of the study.
There were very few cells that were positive for both prepro-
enkephalin and preprotachykinin mRNA [101 of 2154 ENK+ cells
were also SP+ (4.7%); 101 out of 2284 SP+ cells were also
ENK+ (4.4%)], confirming previous reports that, based on mRNA
expression, these two cell populations in the CPu are almost
completely segregated (Gerfen and Young 1988; Albin et al. 1989).
We also determined if there was any effect of treatment condition
on the total number ENK+ or SP+ cells because this could bias
quantification of double-labeled cells. Table 1 shows that there was
no effect of treatment condition on the total number of ENK+ or
SP+ cells in the region of the CPu we sampled.
Statistical analysis
Three sets of comparisons were made: (i) To determine if a
particular treatment induced c-fos mRNA expression above baseline,
data were normalized by subtracting the mean of the home saline
group from the value for each individual subject, and then a planned
one-sample t-test was used to determine whether group means were
significantly greater than zero. (ii) To determine if amphetamine-
induced c-fos mRNA expression varied as a function of context and/
or dose, planned two-way ANOVAs (context, two levels; dose, three
levels) were conducted, followed by Fisher’s PLSD tests for
pairwise comparisons. (iii) To determine if amphetamine adminis-
tered in the novel environment induced levels of c-fos mRNA
expression greater than novelty alone, Fisher’s PLSD tests for
pairwise comparisons were used. For all comparisons a < 0.05.
Results
Expression of c-fos mRNA in the Cpu
Figure 2(a) shows the mean number of c-fos mRNA positive
cells (c-fos+) in the CPu as a function of treatment condition.
All doses of amphetamine given at home or in the novel
environment significantly increased the number of c-fos+ cells
above baseline (p < 0.0005), and the effect of amphetamine
given in the novel environment was greater than the effect of
novelty alone (p < 0.0002). However, there was also a
significant dose by context interaction (F2,53 ¼ 5.78;
p < 0.006). This was because environmental context influ-
enced the ability of the two lower doses of amphetamine (1 and
5 mg/kg) to increase the number of c-fos+ cells, whereas
environment had no effect on the highest dose (10 mg/kg).
Figure 2(b) shows the mean number of c-fos+ cells that
were also positive for SP mRNA (SP/c-fos+) as a function of
treatment condition. All treatments increased the number of
SP/c-fos+ cells above baseline (p < 0.0008) and the effect
of amphetamine given in the novel environment was greater
than the effect of novelty alone (p < 0.01). Higher doses of
amphetamine produced a greater effect than lower doses
(dose, F2,53 ¼ 19.97; p < 0.0001), but there was no effect of
environmental context (context, F1,53 ¼ 0.93; p ¼ 0.3), and
no interaction between context and dose (F2,53 ¼ 2.06;
p ¼ 0.13).
Figure 2(c) shows the mean number of c-fos+ cells that
were also positive for ENK mRNA (ENK/c-fos+), and Fig. 3
Fig. 1 The stippled area indicates the region of the CPu that was
analyzed. Each stippled region is 500 · 500 lm in size.
Table 1 Mean (± SEM) number of ENK+ and SP+ cells in the CPu as
a function of environment and dose
Treatment ENK+ cells SP+ cells
Home 0 264 ± 10 237 ± 7
Home 1 269 ± 19 240 ± 7
Home 5 253 ± 12 242 ± 10
Home 10 253 ± 16 229 ± 8
Novel 0 242 ± 21 228 ± 7
Novel 1 254 ± 18 232 ± 5
Novel 5 253 ± 16 240 ± 11
Novel 10 250 ± 16 229 ± 8
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provides representative examples of cells double-labeled for
c-fos and preproenkephalin. When given at home, amphet-
amine induced c-fos in very few ENK+ cells (only the effect
of 5 mg/kg was statistically significant). When given in the
novel environment the effect of amphetamine on the number
of ENK/c-fos+ cells differed markedly as a function of dose.
Doses of 1 and 5 mg/kg increased the number of ENK/
c-fos+ cells above baseline (p < 0.0001), above that
produced by novelty alone (p < 0.005), and well above that
produced by these doses of amphetamine given at home
(p < 0.0001). In striking contrast, 10 mg/kg did not increase
the number of ENK/c-fos+ cells above baseline or above
novelty alone.
Expression of c-fos mRNA in the subthalamic nucleus
Figure 4 shows the dose-effect curve for amphetamine-
induced c-fos mRNA expression (integrated density) in the
STN as a function of environmental condition. When given at
home, 1 mg/kg of amphetamine failed to induce c-fos mRNA
above baseline, whereas 5 and 10 mg/kg of amphetamine did.
When given in the novel environment, though, all doses of
amphetamine significantly increased c-fosmRNA expression,
both relative to baseline and to saline given in the novel
environment (p < 0.03). In addition, there was a significant
dose by context interaction (F2,52 ¼ 3.18, p < 0.05). When
given in the novel context, 1 and 5 mg/kg of amphetamine
induced greater c-fosmRNA expression relative to when these
doses were given at home (p < 0.03). However, there was no
effect of environment on the highest dose tested (10 mg/kg;
p ¼ 0.44). Figure 5 provides representative sections illustra-
ting c-fos mRNA expression at the level of the STN.
Discussion
We report three main findings: (i) The number of SP+ cells in
the CPu that expressed c-fos mRNA increased progressively
over the dose range studied, whether amphetamine was given
at home or in a novel environment. (ii) The ability of
amphetamine to engage ENK+ cells in the CPu was critically
dependent on an interaction between dose and environmental
context. When given at home, all doses of amphetamine were
relatively ineffective in inducing c-fos mRNA in ENK+ cells.
When given in a novel environment, however, low to
Fig. 4 The expression of c-fos mRNA in the STN of rats given saline
or 1, 5 or 10 mg/kg of amphetamine at home or in a novel environ-
ment, as indicated by analysis of relative integrated optical density
values (arbitrary units).
Fig. 2 The expression of c-fos mRNA in the CPu of rats given saline
or 1, 5 or 10 mg/kg of amphetamine at home or in a novel environ-
ment. (a) The mean (± SEM) number of cells positive for c-fos mRNA
as a function of dose and environmental context. (b) The mean
(± SEM) number of cells positive for c-fos mRNA that were also
positive for preprotachykinin mRNA (SP+) as a function of dose and
environmental context. (c) The mean (± SEM) number of cells positive
for c-fos mRNA that were also positive for preproenkephalin mRNA
(ENK+) as a function of dose and environmental context.
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moderate doses of amphetamine (1 and 5 mg/kg) increased
c-fos mRNA in a substantial number of ENK+ cells. In
striking contrast, a higher dose of amphetamine (10 mg/kg)
failed to induce c-fos in ENK+ cells. (iii) The ability of
amphetamine to engage the STN was modulated by both
dose and environmental context. Environmental novelty
enhanced the ability of low to moderate doses of amphet-
amine to induce c-fos in the STN, but at the highest dose
tested amphetamine induced equally robust c-fos mRNA
expression in either context.
The ability of amphetamine to induce c-fos in ENK+
cells is determined by an interaction between dose
and environmental context
Most previous studies report that amphetamine or cocaine
induces c-fos or Fos-IR almost exclusively in SP+ cells in the
Amphetamine-induced c-fos in ENK+ cells
Novel 5 mg/kg Novel 10 mg/kg
Fig. 3 Representative histological plates
from the CPu illustrating cells double-labe-
led for c-fos mRNA and preproenkephalin
mRNA in animals given either 5 or 10 mg/kg
of amphetamine in the novel environment.
(Top) Darkfield images in which cells pos-
itive for c-fos mRNA are identified by clus-
ters of silver grains. (Bottom) Overlay of
darkfield and brightfield images. Cells pos-
itive for preproenkephalin mRNA are iden-
tified with purple precipitate and cells
positive for c-fos mRNA are identified by
silver grains. Arrows pointing down indicate
cells positive for c-fos but not prepro-
enkephalin mRNA. Arrows pointing up
indicate cells labeled with preproenkephalin
mRNA but not c-fos mRNA. Arrows pointing
to the right indicate double-labeled cells
(c-fos/ENK+).
Fig. 5 Representative sections at the level
of the subthalamic nucleus (STN) from
animals given 5 mg/kg of amphetamine at
home or in the novel context. (a and b)
Emulsion dipped sections illustrating
expression of c-fos mRNA (silver grains).
(a¢ and b¢) Adjacent cresyl violet stained
sections. Stippled region indicates the area
of the STN that was analyzed. The cerebral
peduncle (CP) is labeled to aid with ana-
tomical location.
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CPu (Berretta et al. 1992; Cenci et al. 1992; Berretta et al.
1993; Johansson et al. 1994; Ruskin and Marshall 1994;
Kosofsky et al. 1995; Moratalla et al. 1996; Berke et al.
1998; Harlan and Garcia 1998). As best as we can tell,
however, in these studies amphetamine was administered in
the home cage. Consistent with this we found that when
amphetamine was given at home about 90% of c-fos+ cells
were SP+. We are aware of only one report, other than
studies from our laboratory (Badiani et al. 1998; Uslaner
et al. 2001b), showing that amphetamine induces c-fos or
Fos-IR in significant numbers of ENK+ cells. Jaber et al.
(1995) found that although amphetamine increased Fos-IR
predominantly in SP+ cells (77% of Fos + cells were SP+),
Fos-IR was also found in many ENK+ cells (33% of Fos +
cells were ENK+). Importantly, Jaber et al. (1995) treated
animals in a distinct test cage, different from the animal’s
home cage. We conclude therefore that the apparent selec-
tivity of amphetamine-induced c-fos or Fos-IR for SP+ cells
is likely a function of the context in which the drug is
administered.
However, the ability of environmental novelty to modulate
amphetamine-induced c-fos expression in ENK+ cells was
strongly dose-dependent. When given in the novel environ-
ment 1 and 5 mg/kg of amphetamine significantly increased
the number of c-fos/ENK+ cells, but 10 mg/kg of amphet-
amine did not. This inverted U-shaped dose-effect function
for amphetamine-induced c-fos expression in ENK+ cells has
not been previously reported, presumably because in all the
previous studies where amphetamine was given in a novel
environment doses £ 5 mg/kg were used (Jaber et al. 1995;
Badiani et al. 1999; Uslaner et al. 2001b).
It is generally thought that amphetamine- and cocaine-
induced IEG expression in the CPu is dependent on both
dopamine and glutamate NMDA receptors because dopam-
ine D1 receptor antagonists (Graybiel et al. 1990; Nguyen
et al. 1992; Steiner and Gerfen 1995; Yoshida et al. 1995;
Ishida et al. 1998) and NMDA antagonists (Snyder-Keller
1991; Ohno et al. 1994; Wang et al. 1994; Wang and
McGinty 1996; Ishida et al. 1998) block psychostimulant
drug-induced IEG expression. But these findings may only
apply to IEG expression in SP+ cells, because the pharma-
cology of amphetamine-induced IEG expression in ENK+
cells has never been studied. However, there is reason to
believe that glutamate may be important for the ability of
amphetamine to induce c-fos in ENK+ cells. Disinhibition of
corticostriatal glutamate projections (Arnauld et al. 1996;
Berretta et al. 1997; Parthasarathy and Graybiel 1997;
Gerfen et al. 2002) or local infusion of glutamate agonists
into the CPu (Berretta et al. 1992) enhances c-fos mRNA or
Fos-IR in ENK+ cells, while having little effect on SP+ cells.
Furthermore, mere exposure to a novel environment induces
c-fos expression in a significant number of ENK+ cells in the
CPu. Indeed, the percentage of c-fos/ENK+ cells in animals
exposed to novelty alone (approximately 30% of c-fos+ cells
were ENK+) is very similar to the percentage for animals
given 1 or 5 mg/kg of amphetamine in the novel environ-
ment, even though the absolute number of c-fos/ENK+ cells
is much less. Exposure to a novel environment also induces
marked c-fos expression throughout the neocortex (Badiani
et al. 1998; Uslaner et al. 2001a). Therefore, induction of
c-fos in ENK+ cells produced by mere exposure to novelty
may reflect activation of corticostriatal glutamate projections,
and amphetamine-induced dopamine release may amplify
this effect. Indeed, it is well known that dopamine can
enhance the ability of glutamate to engage striatal cells (see
below). In support of this hypothesis we recently found that
amphetamine-induced c-fos expression in ENK+ cells is
preferentially attenuated by low doses of a dopamine D1 or
D2 receptor antagonist, a non-selective NMDA receptor
antagonist, and an NMDA antagonist specific for the NR2B
subunit (Ferguson et al. 2002).
Assuming that a dopamine/glutamate interaction is
important for the ability of 1 and 5 mg/kg of amphetamine
to induce c-fos in ENK+ cells, why would 10 mg/kg fail to
induce c-fos in these same cells? First, it is important to note
that this inverted U-shaped dose-effect curve is not specific
to amphetamine-induced c-fos mRNA expression in ENK+
cells. The ability of amphetamine to induce arc mRNA
expression in ENK+ cells is also characterized by an
inverted-U shaped dose-effect curve (unpublished observa-
tions). In addition, low doses of methamphetamine increase
neuropeptide immunoreactivity and release in the caudate-
putamen but high doses have either no effect or the opposite
effect (Wagstaff et al. 1996; Alburges et al. 2001; Hanson
et al. 2002). Finally, in situations where low doses of
amphetamine increase the firing rate of cells in the CPu,
higher doses can decrease firing rate (Rebec and Curtis 1983;
Gardiner et al. 1988).
Given these differences between high and low doses of
amphetamine, it is tempting to conclude that amphetamine
recruits different neurotransmitter systems and/or intracellu-
lar signaling pathways as a function of dose, which could be
true. It is also possible, however, that an interaction between
dopamine and glutamate underlies both the increased
response of ENK+ cells to moderate doses of amphetamine
given in the novel environment, and the lack of response to
higher doses. Although the interaction between dopamine
and glutamate is yet to be clearly elucidated, and there are
conflicting results (see Nicola et al. 2000 for review), many
electrophysiological studies suggest that the interaction
between dopamine and glutamate is not linear. Using
single-unit recording techniques it has been shown that local
application of low levels of DA enhance the response to
iontophoretically applied glutamate in most striatal cells in
anesthetized (Chiodo and Berger 1986; Hu and Wang 1988;
Hu et al. 1990; Kiyatkin and Rebec 1996; Hu and White
1997) and freely moving rats (Nisenbaum et al. 1988), as
well as in striatal cells administered a depolarizing pulse
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(Akaike et al. 1987). In contrast, this effect is reversed at
higher DA levels, which inhibit glutamatergic-induced
neuronal firing. This occurs not only in the striatum, but
also in the medial prefrontal cortex, where low levels of
dopamine enhance the inward current produced by NMDA,
but higher concentrations suppress the inward current (Zheng
et al. 1999). Importantly, the ability of amphetamine to
enhance extracellular dopamine in the CPu increases
progressively between 1 and 10 mg/kg (Sharp et al. 1987;
Butcher et al. 1988). Therefore, low and moderate doses of
amphetamine may increase dopamine to levels that enhance
glutamatergic activity, whereas the even greater levels of
synaptic dopamine produced by very high doses of amphet-
amine may suppress glutamatergic activity. Given the role of
glutamate in mediating IEG expression in ENK+ cells
(discussed above), we speculate that the differential ability of
high and low levels of dopamine to modulate glutamate
activity in the CPu may be responsible for the inverted U-
shaped dose-effect curve for amphetamine-induced c-fos in
ENK+ cells.
The effect of amphetamine on the STN
The ability of amphetamine to increase c-fos expression in the
STN has been reported previously (Wirtshafter and Asin
1999), and we recently found that environmental novelty
enhances amphetamine- and cocaine-induced c-fos expres-
sion in the STN, relative to drug given at home (Ostrander
et al. 2000; Uslaner et al. 2001b). Here we extend this finding
to other doses of amphetamine (1 and 5 mg/kg), and show
that the ability of novelty to enhance amphetamine-induced
c-fos expression in the STN is dose-dependent. Specifically,
at the highest dose examined (10 mg/kg) amphetamine
enhanced c-fos expression in the STN to the same extent
when it was given at home or in the novel environment.
Unfortunately, the neural mechanisms by which amphet-
amine engages the STN are largely unknown. We had
previously hypothesized that the recruitment of ENK+ cells
in the CPu may enhance c-fos mRNA expression in the STN
by engaging the ‘indirect’ pathway. Standard descriptions of
this circuit predict that engaging ENK+ cells should
influence the STN via the striato-pallidal-STN pathway
(Albin et al. 1989; Crossman 1990). However, our current
results suggest that engaging the ‘indirect’ pathway is not the
only means by which amphetamine induces c-fos in the STN,
because high doses given at home or in the novel environ-
ment did not appear to engage ENK+ cells in the CPu, but
did engage the STN. Consistent with this, others have
reported that STN activity is not solely dependent upon the
‘indirect’ pathway. For example, a lesion of the globus
pallidus, which prevents ENK+ cells from interacting with
the STN through the ‘indirect’ pathway, has little effect on
the ability of amphetamine to increase neuronal firing in the
STN (Olds et al. 1998). Of course, the STN receives
numerous projections, many of which could mediate the
effects described here (Parent and Hazrati 1995). For
example, the STN receives a direct DA input from the
substantia nigra pars compacta (SNc) and ventral tegmental
area (VTA) (Campbell et al. 1985; Canteras et al. 1990;
Hassani et al. 1997) and DA agonists enhance neural activity
(Mintz et al. 1986; Kreiss et al. 1996; Kreiss et al. 1997; Ni
et al. 2001) and c-fos expression in the STN (Ruskin and
Marshall 1995; Svenningsson and Le Moine 2002). In
addition, the STN receives efferents from the prefrontal
cortex (Canteras et al. 1990) and cortical stimulation enhan-
ces neuronal firing (Maurice et al. 1998) and c-fos expres-
sion in the STN (Sgambato et al. 1997). The possible
influence of these circuits is particularly intriguing, given that
the VTA, SNc, and the prefrontal cortex have been strongly
implicated in the long-lasting behavioral and neurobiological
effects of amphetamine (Eichler and Antelman 1979; Rob-
inson et al. 1985; Vezina and Stewart 1990; Banks and
Gratton 1995; Pierce and Kalivas 1997; Vanderschuren and
Kalivas 2000).
The relationship between the ability of amphetamine
to engage the STN, ENK+ cells and behavioral
sensitization
Amphetamine produces more robust behavioral sensitization
when it is administered repeatedly in a distinct and relatively
novel environment, compared with when it is given in the
home cage (Badiani et al. 1995a; Badiani et al. 1995b;
Crombag et al. 1996; Badiani et al. 1997), but the ability of
environmental context to modulate behavioral sensitization is
dose-dependent. As dose is increased amphetamine induces
robust behavioral sensitization at home and in a novel
environment (Browman et al. 1998b). Therefore, if engaging
ENK+ cells in the CPu were necessary to induce the robust
behavioral sensitization produced by high doses, as dose is
increased amphetamine should come to induce c-fos in
ENK+ cells even when given at home. This did not happen.
When given at home not only did increasing doses of
amphetamine fail to recruit ENK+ cells, but so did 10 mg/kg
given in the novel environment. This does not support the
idea that engaging ENK+ cells, at least as indicated by c-fos
mRNA expression, is critical to produce robust behavioral
sensitization under all conditions.
Nevertheless, it is still possible that engaging the ‘indirect
pathway’ (as indicated by c-fos expression in ENK+ cells) is
responsible for the modulatory effect of context on sensiti-
zation. At low to moderate doses the induction of sensitiza-
tion is facilitated by giving amphetamine in a distinct context,
and this may be due to the recruitment of corticostriatal
glutamate inputs, which is reflected by c-fos mRNA induc-
tion in ENK+ cells. At higher doses, however, the modula-
tory effect of environment on sensitization is lost, as is the
ability to engage ENK+ cells. Thus, the neural mechanisms
underlying the induction of sensitization may be qualitatively
different depending upon the context surrounding drug
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treatment and the dose of drug given. Obviously, this
possibility carries significant implications for understanding
the neurobiological mechanisms underlying sensitization.
Finally, the data reported here suggest that the role of the
STN in sensitization may be under-appreciated. Low doses
of amphetamine, which only produce sensitization when
given in a novel environment, also induce c-fos in the STN
only when given in a novel environment. As dose is
increased, however, and the influence of context weakens,
amphetamine begins to induce c-fos in the STN regardless
of environmental context. Thus, there is a similar interac-
tion between dose and context in producing sensitization
and engaging the STN (as indicated by c-fos mRNA
expression). The role of the STN in sensitization is
unknown, but it is worth noting that activation of the
STN enhances dopamine efflux in the striatum by increas-
ing activity in the SNc (Smith and Grace 1992). Further-
more, stimulation of the STN can induce long-term
potentiation (LTP) in the SNc (Overton et al. 1999). Given
the hypothesized relationship between LTP, dopamine
release, and behavioral sensitization (Wolf 1998; Hyman
and Malenka 2001), further investigation of the role of the
STN in sensitization is warranted.
In conclusion, this study clearly shows that the ability of
amphetamine to engage neural circuits involved in the
psychomotor activating and incentive motivational effects of
drugs of abuse is powerfully modulated by the context in
which drugs are administered, and that the effects of context
interact with the effects of dose. This may be one reason why
‘set and setting’ are so important in modulating both the
acute behavioral and subjective effects of drugs (Falk and
Feingold 1987), as well as their ability to induce forms of
drug experience-dependent plasticity, such as behavioral
sensitization (Robinson et al. 1998).
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